Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victoza in children and adolescents with type 2 diabetes
NCT01541215Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2012
- Primary completion
- Nov 2017
- Modality
- Peptides
- Countries
- 36
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Liraglutide + Metformin with Placebo + Metformin (2 arms). Primary endpoint: Change in Glycosylated Haemoglobin at 26 weeks. Started Nov 2012; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01541215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541215.